News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
668,126 Results
Type
Article (56178)
Company Profile (119)
Press Release (612142)
Multimedia
Podcasts (220)
Webinars (28)
Section
Business (198542)
Career Advice (2745)
Deals (31799)
Drug Delivery (182)
Drug Development (78148)
Employer Resources (183)
FDA (17050)
Job Trends (14035)
News (308494)
Policy (33400)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (6)
Academia (2848)
Academic (1)
Accelerated approval (63)
ADA (50)
Adcomms (43)
Allergies (206)
Alliances (44150)
ALS (241)
Alzheimer's disease (2017)
Antibody-drug conjugate (ADC) (576)
Approvals (17452)
Artificial intelligence (812)
ASCO (323)
Autoimmune disease (385)
Automation (66)
Bankruptcy (334)
Best Places to Work (10803)
BIO (74)
Biologics (1)
BIOSECURE Act (23)
Biosimilars (261)
BioSpace Insights (195)
Biotechnology (74)
Bladder cancer (222)
Brain cancer (81)
Breast cancer (824)
Cancer (6646)
Cardiovascular disease (578)
Career advice (2344)
Career pathing (57)
CAR-T (364)
CDC (77)
Celiac Disease (3)
Cell therapy (1035)
Cervical cancer (58)
Clinical research (68558)
Collaboration (2300)
Commercialization (8)
Company closure (8)
Compensation (1627)
Complete response letters (120)
COVID-19 (2923)
CRISPR (126)
C-suite (1365)
Cystic fibrosis (171)
Data (8972)
Decentralized trials (3)
Denatured (79)
Depression (206)
Dermatology (113)
Diabetes (707)
Diagnostics (6739)
Digital health (62)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (399)
Drug pricing (244)
Drug shortages (36)
Duchenne muscular dystrophy (350)
Earnings (71949)
Editorial (82)
Employer branding (21)
Employer resources (163)
Events (102137)
Executive appointments (1207)
FDA (21379)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (25)
Frontotemporal dementia (36)
Funding (1877)
Gene editing (273)
Generative AI (74)
Gene therapy (861)
GLP-1 (1267)
Government (5047)
Grass and pollen (8)
Guidances (430)
Healthcare (18553)
Hematology (190)
HIV (104)
Huntington's disease (72)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (127)
Immunology and inflammation (372)
Immuno-oncology (117)
Indications (227)
Infectious disease (3329)
Inflammatory bowel disease (233)
Inflation Reduction Act (15)
Influenza (149)
Intellectual property (336)
Interviews (513)
IPO (15208)
IRA (58)
Job creations (3457)
Job search strategy (1911)
JPM (69)
Kidney cancer (26)
Labor market (121)
Layoffs (677)
Leadership (56)
Legal (7688)
Licensing (9)
Liver cancer (107)
Longevity (36)
Lung cancer (882)
Lymphoma (497)
Machine learning (63)
Management (65)
Manufacturing (1264)
Marketing (14)
MASH (235)
Medical affairs (1)
Medical device (13201)
Medtech (13406)
Mergers & acquisitions (17957)
Metabolic disorders (1855)
mRNA (269)
Multiple sclerosis (209)
NASH (24)
Neurodegenerative disease (534)
Neuropsychiatric disorders (135)
Neuroscience (3838)
Neurotech (2)
NextGen: Class of 2026 (6284)
Non-profit (4847)
Now hiring (79)
Obesity (886)
Opinion (348)
Ovarian cancer (242)
Pain (280)
Pancreatic cancer (369)
Parkinson's disease (428)
Partnered (35)
Patents (687)
Patient recruitment (848)
Peanut (70)
People (55253)
Pharmaceutical (30)
Pharmacy benefit managers (38)
Phase 1 (20736)
Phase 2 (29929)
Phase 3 (23416)
Pipeline (10931)
Policy (407)
Postmarket research (2677)
Preclinical (8948)
Press Release (64)
Prostate cancer (363)
Psychedelics (83)
Radiopharmaceuticals (361)
Rare diseases (1392)
Real estate (5221)
Recruiting (76)
Regulatory (27173)
Reports (61)
Research institute (2557)
Resumes & cover letters (435)
Rett syndrome (50)
RNA editing (30)
RSV (99)
Schizophrenia (201)
Series A (318)
Series B (237)
Service/supplier (10)
Sickle cell disease (132)
Special edition (32)
Spinal muscular atrophy (185)
Sponsored (54)
Startups (3327)
State (1)
Stomach cancer (21)
Supply chain (145)
Tariffs (105)
The Weekly (139)
Vaccines (1311)
Venture capital (147)
Weight loss (606)
Women's health (140)
Worklife (25)
Date
Today (134)
Last 7 days (700)
Last 30 days (2561)
Last 365 days (30646)
2026 (19441)
2025 (30163)
2024 (34064)
2023 (38320)
2022 (49137)
2021 (53430)
2020 (51666)
2019 (44185)
2018 (33461)
2017 (31351)
2016 (30380)
2015 (34032)
2014 (27027)
2013 (22265)
2012 (24014)
2011 (24428)
2010 (22547)
Location
Africa (884)
Alabama (85)
Alaska (6)
Arizona (342)
Arkansas (15)
Asia (38467)
Australia (6853)
California (14307)
Canada (3672)
China (1490)
Colorado (580)
Connecticut (658)
Delaware (428)
Europe (93612)
Florida (2206)
Georgia (449)
Hawaii (5)
Idaho (54)
Illinois (1178)
India (113)
Indiana (607)
Iowa (26)
Japan (632)
Kansas (136)
Kentucky (49)
Louisiana (55)
Maine (86)
Maryland (1735)
Massachusetts (10277)
Michigan (335)
Minnesota (773)
Mississippi (6)
Missouri (156)
Montana (24)
Nebraska (28)
Nevada (149)
New Hampshire (85)
New Jersey (3825)
New Mexico (31)
New York (3737)
North Carolina (1851)
North Dakota (11)
Northern California (7337)
Ohio (440)
Oklahoma (27)
Oregon (41)
Pennsylvania (2727)
Puerto Rico (30)
Rhode Island (38)
South America (1219)
South Carolina (90)
South Dakota (2)
Southern California (5694)
Tennessee (238)
Texas (2280)
United States (50380)
Utah (422)
Vermont (2)
Virginia (366)
Washington D.C. (81)
Washington State (1131)
West Virginia (4)
Wisconsin (150)
Wyoming (2)
668,126 Results for "children s organ transplant association cota".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capital
LifeMine raises $263M in mission to improve organ transplant aftercare
Patients who receive an organ transplant must take difficult immuno-suppressive medicines for the rest of their lives. LifeMine Therapeutics wants to offer a safer alternative.
August 6, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination
July 16, 2026
·
3 min read
Press Releases
TolerogenixX Completes Last Patient Transplant in Phase IIb TOL-2 Trial of MIC-Lx, Advancing a New Immune Tolerance Approach in Kidney Transplantation
· All 63 donor-recipient pairs enrolled and treated according to protocol across multiple clinical centers · Randomized, controlled Phase IIb trial evaluating TolerogenixX’s proprietary MIC technology, a first-in-class immune tolerance-inducing cell therapy, in living-donor kidney transplantation · Designed to address one of transplantation’s key issues: lifelong systemic immunosuppression · Key milestone in the clinical development of MIC-Lx and TolerogenixX’s proprietary MIC technology platform
June 29, 2026
·
1 min read
Press Releases
Kambiz Etesami, MD, FACS, Named Division Chief of Abdominal Organ Transplantation at Children’s Hospital Los Angeles
November 3, 2025
·
3 min read
Press Releases
Ichnos Glenmark Innovation (IGI) Announces Appointment of Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer
June 23, 2026
·
2 min read
Press Releases
Children’s Hospital of Philadelphia Study May Help Explain Why Some Children with Sepsis or Organ Failure Face a Harder Recovery
June 11, 2026
·
5 min read
Press Releases
Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference
June 15, 2026
·
4 min read
Press Releases
TolerogenixX Has Received EMA Orphan Drug Designation for MIC-Lx, Strengthening its Regulatory Pathway in Kidney Transplantation
· Supporting the development of its proprietary MIC-Lx Modified Immune Cells technology as a novel approach to reduce lifelong systemic immunosuppression and improve long-term outcomes for transplant recipients · Strengthening MIC-Lx’s regulatory and commercial positioning in Europe
July 13, 2026
·
1 min read
Press Releases
Picard Medical / SynCardia Highlights Total Artificial Heart Bridge to Transplant Case at Texas Children’s Hospital
April 15, 2026
·
5 min read
Press Releases
Tri Delta Reaches $25M Milestone for St. Jude Children’s Research Hospital
June 15, 2026
·
3 min read
1 of 66,813
Next
